Breaking News - The Fly

Open Search

MNOV

MediciNova

$

()

MediciNova gets notice of allowance from Japan for pending patent for MN-166

MNOV

3/26/2024 - 19:01pm

MediciNova's two abstrats regarding MN-001 and MN-002 accepted at EAS

MNOV

3/20/2024 - 19:13pm

MediciNova's MN-166 shows efficacy in lung injury study

MNOV

3/12/2024 - 06:35am

MediciNova receives Notice of Grant for new patent covering MN-166

MNOV

1/17/2024 - 06:02am

MediciNova announces abstract regarding MN-166 or ibudilast

MNOV

12/21/2023 - 18:02pm

MediciNova granted new patent covering MN-166 for progressive MS in Europe

MNOV

12/6/2023 - 18:03pm

Biotech Alert: Searches spiking for these stocks today

MNOV , NSTG , HOOK

…

11/22/2023 - 10:52am

MediciNova announces new data, results of Phase 2 trial of MN-166 in GBM

MNOV

11/19/2023 - 18:17pm

MediciNova discloses notice of allowance for new patent on MN-166 + Riluzole

MNOV

10/10/2023 - 19:01pm

MediciNova receives gene therapy milestone payment

MNOV , SNY

10/4/2023 - 19:00pm

MediciNova announces results of MN 166 studies under BARDA contract

MNOV

9/27/2023 - 19:11pm

MediciNova's abstact on MN-166 in glioblastoma selected for SNO presentation

MNOV

8/17/2023 - 19:01pm

MediciNova receives notice of intention to grant new patent for MN-166

MNOV

8/16/2023 - 19:11pm

MediciNova receives new patent covering MN-001

MNOV

8/15/2023 - 19:00pm

MediciNova's MN-166 does not show efficacy in alcoholism trial

MNOV

6/29/2023 - 06:08am